Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: A comparative study between natural cycle IVF and conventional IVF

Human Reproduction

Volumn 29, Issue 5, 2014, Pages 1049-1057

  Von Wolff, M ^a   Kollmann, Z ^a   Fluck C E ^b   Stute, P ^a   Marti, U ^c   Weiss, B ^a   Bersinger, N A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b University Children's Hospital   (Switzerland)

^c MCL Medical Laboratories   (Switzerland)

Author keywords

androgens; follicular fluid; infertility; IVF outcome; natural cycle

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; AROMATASE; ESTRADIOL; FOLLITROPIN; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PRASTERONE; PROGESTERONE; TESTOSTERONE;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; COMPARATIVE STUDY; CONVENTIONAL GONADOTROPHIN STIMULATED IN VITRO FERTILIZATION; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR ASPIRATION; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; NATURAL CYCLE IN VITRO FERTILIZATION; OOCYTE RETRIEVAL; OVARY FOLLICLE CELL; OVARY FOLLICLE FLUID; TESTOSTERONE BLOOD LEVEL; CHEMISTRY; OVULATION INDUCTION; PROCEDURES; YOUNG ADULT;

ADULT; ANDROSTENEDIONE; ANTI-MULLERIAN HORMONE; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; TESTOSTERONE; YOUNG ADULT;

EID: 84898911324     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu044     Document Type: Article

References (27)

1. Aanesen A, Nygren KG, Nylund L. Modified natural cycle IVF and mild IVF: a 10 year Swedish experience. Reprod Biomed Online 2010;20:156-162.
2. Andersen CY, Lossl K. Increased intrafollicular androgen levels affect human granulosa cell secretionofanti-Müllerian hormone andinhibin-B. Fertil Steril 2008;89:1760-1765.
3. Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 2006; 21:3217-3227.
4. Baruffi RL, Mauri AL, Petersen CG, Felipe V, Martins AM, Cornicelli J, Cavagna M, Oliveira JB, Franco JG Jr. Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the Gn RH-antagonist protocol: a meta-analysis. Reprod Biomed Online 2007; 14:14-25.
5. Check JH, Katsoff B, Brasile D, Choe JK, Amui J. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women of more advanced reproductive age with elevated serum follicle stimulating hormone (FSH) levels. Clin Exp Obstet Gynecol 2008;35:13-15.
6. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-362.
7. DIR. German IVF registry. www.deutsches-ivf-register.de.
8. Durnerin CI, Erb K, Fleming R, Hillier H, Hillier SG, Howles CM, Hugues JN, Lass A, Lyall H, Rasmussen P et al. Luveris Pretreatment Group. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Hum Reprod 2008;23:421-426.
9. Fanchin R, Louafi N, Méndez Lozano DH, Frydman N, Frydman R, Taieb J. Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status. Fertil Steril 2005;84:167-173.
10. Fanchin R, Mendez Lozano DH, Frydman N, Gougeon A, di Clemente N, Frydman R, Taieb J. Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab 2007;92:1796-1802.
11. FIVNAT. Swiss IVF registry. http://www.sgrm.org/wb/media/FIVNAT/FIVNAT- Statistik-2010-vs-05.04.2012.pdf.
12. Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertil Steril 2013;100:1622-1628. e3.
13. Grossman MP, Nakajima ST, Fallat ME, Siow Y. Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril 2008;89(5 Suppl):1364-1370.
14. Hill MJ, Levens ED, Levy G, Ryan ME, Csokmay JM, De Cherney AH, Whitcomb BW. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age:a systematic review and meta-analysis. Fertil Steril 2012;97:1108-1114.
15. Kolibianakis EM, Venetis CA, Bontis J, Tarlatzis BC. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with Gn RH antagonists and gonadotrophins: a systematic review and meta-analysis. Curr Pharm Biotechnol 2012;13:464-470.
16. Lephart ED, Simpson ER. Assay of aromatase activity. In: Waterman MR, Johnson EF (eds). Methods in Enzymology. San Diego: Academic Press, 1991, 477-483.
17. Lisi F, Rinaldi L, Fishel S, Caserta D, Lisi R, Campbell A. Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization. Fertil Steril 2005;83:309-315.
18. Nakahara K, Saito H, Saito T, Ito M, Ohta N, Takahashi T, Hiroi M. The incidence of apoptotic bodies in membrana granulosa can predict prognosis of ova from patients participating in in vitro fertilization programs. Fertil Steril 1997;68:312-317.
19. Pabuccu R, Kaya C, Caglar GS, Oztas E, Satiroglu H. Follicular-fluid anti-Mullerian hormone concentrations are predictive of assisted reproduction outcome in PCOS patients. Reprod Biomed Online 2009; 19:631-637.
20. Pandey AV, Kempná P, Hofer G, Mullis PE, Flück CE. Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase. Mol Endocrinol 2007;21:2579-2595.
21. Phy JL, Conover CA, Abbott DH, Zschunke MA, Walker DL, Session DR, Tummon IS, Thornhill AR, Lesnick TG, Dumesic DA. Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. J Clin Endocrinol Metab 2004;89:3561-3566.
22. Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil Steril 2007;87: 542-546.
23. Salmon NA, Handyside AH, Joyce IM. Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice. Dev Biol 2004;266:201-208.
24. Smitz J, Andersen AN, Devroey P, Arce JC; MERIT Group. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod 2007;22:676-687.
25. Takahashi C, Fujito A, Kazuka M, Sugiyama R, Ito H, Isaka K. Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril 2008; 89:586-591.
26. Vigier B, Picard JY, Tran D, Legeai L, Josso N. Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 1984;114:1315-1320.
27. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951-2956.